Lymphatic space invasion is not an independent predictor of outcomes in early stage breast cancer treated by breast-conserving surgery and radiation

Breast Journal

Volumn 18, Issue 5, 2012, Pages 415-419

  Freedman, Gary M ^b   Li, Tianyu ^a   Polli, Leonardo V ^c   Anderson, Penny R ^a   Bleicher, Richard J ^a   Sigurdson, Elin ^a   Swaby, Ramona ^a   Dushkin, Holly ^a   Patchefsky, Arthur ^a   Goldstein, Lori ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c RadioOncologia ^*  (Brazil)

Author keywords

breast cancer; lymphovascular invasion; radiation therapy

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER GRADING; CANCER INVASION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLIMACTERIUM; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INDEPENDENT VARIABLE; LOCAL RECURRENCE FREE SURVIVAL; LYMPH VESSEL METASTASIS; LYMPHATIC SPACE INVASION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARTIAL MASTECTOMY; POSTMENOPAUSE; POSTOPERATIVE CARE; SURVIVAL TIME; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84866112921     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2012.01271.x     Document Type: Article

References (21)

1. Nime FA, Rosen PP, Thaler HT, et al. Prognostic significance of tumor emboli in intramammary lymphatics in patients with mammary carcinoma. Am J Surg Pathol 1977; 1: 25-30.
2. Clemente CG, Boracchi P, Andreola S, et al. Peritumoral lymphatic invasion in patients with node-negative mammary duct carcinoma. Cancer 1992; 69: 1396-403.
3. Pinder SE, Ellis IO, Galea M, et al. Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology 1994; 24: 41-7.
4. Chadha M, Chabon AB, Friedmann P, et al. Predictors of axillary lymph node metastases in patients with T1 breast cancer. A multivariate analysis. Cancer 1994; 73: 350-3.
5. Fisher ER, Anderson S, Tan-Chiu E, et al. Fifteen-year prognostic discriminants for invasive breast carcinoma. National surgical adjuvant breast and bowel project protocol-06. Cancer 2001; 91: 1679-87.
6. Ejlertsen B, Jensen M-B, Rank F, et al. Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer. J Natl Cancer Inst 2009; 101: 729-35.
7. Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 1989; 17: 719-25.
8. Borger J, Kemperman H, Hart A, et al. Risk factors in breast-conservation therapy. J Clin Oncol 1994; 12: 653-60.
9. Veronesi U, Marubini E, Del Vecchio M, et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 1995; 87: 19-27.
10. Magee B, Swindell R, Harris M, et al. Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results from a randomised trial. Radiother Oncol 1996; 39: 223-7.
11. Cowen D, Jacquemier J, Houvenaeghel G, et al. Local and distant recurrence after conservative mamangement of "very low-risk" breast cancer are dependent events: a 10-year follow-up. Int J Radiat Oncol Biol Phys 1998; 41: 801-7.
12. Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 2001; 19: 1688-97.
13. Kurtz JM, Jacquemier J, Amalric R, et al. Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer 1990; 65: 1867-78.
14. Burke M-F, Allison R, Tripcony L,. Conservative therapy of breast cancer in Queensland. Int J Radiat Oncol Biol Phys 1995; 31: 295-303.
15. Leborgne F, Leborgne JH, Ortega B, et al. Breast conservation treatment of early stage breast cancer: patterns of failure. Int J Radiat Oncol Biol Phys 1995; 31: 765-75.
16. Kim SH, Simkovich-Heerdt A, Tran KN, et al. Women 35 years of age or younger have higher locoregional relapse rates after undergoing breast conservation therapy. J Am Coll Surg 1998; 187: 1-8.
17. Elkhuizen PH, Voogd AC, van den Broek LC, et al. Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: a case-control study of histological factors and alterations in oncogene expression. Int J Radiat Oncol Biol Phys 1999; 45: 73-83.
18. Touboul E, Buffat L, Belkacémi Y, et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 1999; 43: 25-38.
19. Cowen D, Houvenaeghel G, Bardou V-J, et al. Local and distant failures after limited surgery with positive margins and radiotherapy for node-negative breast cancer. Int J Radiat Oncol Biol Phys 2000; 47: 305-12.
20. Lee AH, Pinder SE, Macmillan RD, et al. Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. Eur J Cancer 2006; 42: 357-62.
21. Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009; 74: 987-1001.